News + Events

TitleDate
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™Jul 12, 2022
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual MeetingJun 6, 2022
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®Jun 1, 2022
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual ConferenceMay 31, 2022
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®May 12, 2022
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®Apr 27, 2022
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking AbilityApr 26, 2022
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®Dec 14, 2021
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial SiteNov 8, 2021
Helius Medical, Inc. Receives U.S. Marketing Authorization for the PoNS™ DeviceMar 29, 2021
Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory BoardOct 8, 2020
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple SclerosisMay 12, 2020